Informações:
Falhas:
ID
34209
Descrição
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases; ODM derived from: https://clinicaltrials.gov/show/NCT02419677
Link
https://clinicaltrials.gov/show/NCT02419677
Palavras-chave
Versões (1)
- 15/01/2019 15/01/2019 -
Titular dos direitos
see on clinicaltrials.gov
Transferido a
15 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Colorectal Cancer NCT02419677
Eligibility Colorectal Cancer NCT02419677
- StudyEvent: Eligibility
Similar models
Eligibility Colorectal Cancer NCT02419677
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
patients with histologically confirmed adenocarcinoma
boolean
ID.2
Item
primary lesions (colorectal cancer) are resected
boolean
ID.3
Item
must have undergone prior complete resection of the primary tumor; liver metastases
boolean
ID.4
Item
must be resectable or accessible for radiofrequency ablation (five or less lung metastases measuring 5 cm or smaller).
boolean
ID.5
Item
serum bilirubin level of 2.0 mg/dl or less.
boolean
ID.6
Item
performance status of 0 or 1.
boolean
ID.7
Item
expected survival of 1 year or more.
boolean
ID.8
Item
informed consent from the patient.
boolean
ID.9
Item
with extrahepatic metastases
boolean
ID.10
Item
with other neoplastic disease that is measurable or being treated other than colorectal cancer.
boolean